Floatz logo

Monomethyl Fumarate

AIDS-related Primary CNS Lymphoma

Fred Hutchinson Cancer CenterSmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the AIDS-related Primary CNS Lymphoma cohort.

Asset / SponsorPhaseRating
Hycamtin
National Cancer Institute (NCI)
Phase 2B
Cediranib
National Cancer Institute (NCI)
Phase 1CCC
Procarbazine
National Cancer Institute (NCI)
Phase 1CC
Capecitabine
National Cancer Institute (NCI)
Phase 1CC
Irinotecan
National Cancer Institute (NCI)
Phase 1CC

View all 12 →

Same molecule, other indications

Monomethyl Fumarate is also rated in:

Blood Stem Cell Transplant FailureDormant
BBB
Indicative ·
76 / 100
View asset →
Fanconi AnemiaDormant
BBB
Indicative ·
74 / 100
View asset →
Refractory Anemia With Excess BlastsDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →